FDA Import Refusal SCS-2080222-3/12/1 — HUBPLATFORM
The FDA refused shipment SCS-2080222-3/12/1 from HUBPLATFORM (South Korea) on Feb 2, 2024. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3000,483,75
Refusal details
- Date
- Feb 2, 2024
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VBY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3000,483,75